TransMedics Group (TMDX)
(Real Time Quote from BATS)
$167.57 USD
+1.59 (0.96%)
Updated Sep 20, 2024 11:00 AM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for TransMedics Group, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -25.03 | -36.23 | -44.22 | -28.75 | -33.55 |
Depreciation/Amortization & Depletion | 8.18 | 3.48 | 1.82 | 1.58 | 1.22 |
Net Change from Assets/Liabilities | -44.35 | -26.76 | 3.00 | -5.59 | -1.63 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 48.17 | 13.70 | 10.53 | 2.49 | 1.67 |
Net Cash From Operating Activities | -13.03 | -45.82 | -28.86 | -30.27 | -32.29 |
Property & Equipment | -179.06 | -11.91 | -3.52 | -0.46 | -0.17 |
Acquisition/ Disposition of Subsidiaries | -14.89 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 66.42 | 32.79 | -41.14 | -60.34 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -193.95 | 54.51 | 29.27 | -41.60 | -60.50 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.11 | 145.47 | 1.39 | 76.25 | 97.57 |
Issuance (Repayment) of Debt | 393.31 | 22.46 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -0.71 | -4.85 |
Net Cash from Financing Activities | 400.42 | 167.93 | 1.39 | 75.55 | 92.72 |
Effect of Exchange Rate Changes | 0.19 | -1.02 | -0.80 | 0.80 | -0.09 |
Net Change In Cash & Equivalents | 193.63 | 175.60 | 1.00 | 4.49 | -0.15 |
Cash at Beginning of Period | 201.68 | 26.08 | 25.08 | 20.59 | 20.74 |
Cash at End of Period | 395.31 | 201.68 | 26.08 | 25.08 | 20.59 |
Diluted Net EPS | -0.77 | -1.23 | -1.60 | -1.16 | -2.36 |
Fiscal Year End for TransMedics Group, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 24.39 | 12.20 | -25.03 | -29.06 | -3.64 |
Depreciation/Amortization & Depletion | 8.90 | 4.30 | 8.18 | 4.57 | 2.68 |
Net Change from Assets/Liabilities | -27.92 | -28.10 | -44.35 | -38.79 | -23.25 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 16.91 | 8.16 | 48.17 | 41.94 | 9.75 |
Net Cash From Operating Activities | 22.28 | -3.44 | -13.03 | -21.33 | -14.46 |
Property & Equipment | -67.94 | -44.17 | -179.06 | -137.24 | -2.31 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -14.89 | -14.89 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -67.94 | -44.17 | -193.95 | -152.14 | -2.31 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 13.83 | 3.19 | 7.11 | 6.19 | 4.66 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 393.31 | 393.31 | 393.31 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 13.83 | 3.19 | 400.42 | 399.49 | 397.97 |
Effect of Exchange Rate Changes | -0.24 | -0.17 | 0.19 | -0.10 | 0.08 |
Net Change In Cash & Equivalents | -32.06 | -44.60 | 193.63 | 225.93 | 381.28 |
Cash at Beginning of Period | 395.31 | 395.31 | 201.68 | 201.68 | 201.68 |
Cash at End of Period | 363.25 | 350.72 | 395.31 | 427.61 | 582.96 |
Diluted Net EPS | 0.35 | 0.35 | 0.12 | -0.78 | -0.03 |